Ted Ebel serves as Chief Business Officer at Colorescience.
Mr. Ebel has 20 years of experience in the health, wellness and consumer products industries.
Prior to Colorescience, Mr. Ebel was Senior Vice President of Corporate Development for SkinMedica, Inc. having responsibility for mergers and acquisitions, licensing, intellectual property management, market research and establishing the company’s international operations.
Earlier in his career, Mr. Ebel served as the Executive Director of Corporate Development at CancerVax Corporation, a biotechnology company focused on cancer immunotherapy, and as the Vice President of Strategic Ventures for MP3.com, a publicly traded internet and entertainment company.
In addition, Mr. Ebel held positions in marketing and corporate development at Amgen, Inc. and began his career as a consultant in the health care practice of the management consulting firm Arthur D. Little. Mr. Ebel received his Bachelor of Science, Magna Cum Laude, from Duke University, and his MBA from the Wharton School at the University of Pennsylvania.